Status:
COMPLETED
Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Källmark Clinic
Conditions:
Keratoconjunctivitis Sicca (KCS)
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate how treatment with Intra-Nasal Mechanical Stimulation (INMEST) in the nasal cavity in patients with Keratoconjunctivitis sicca can relieve these symtoms.
Eligibility Criteria
Inclusion
- Ocular surface disease index, OSDI \> 12 points.
- Non-invasive breakup time, NIBUT \< 11 seconds.
Exclusion
- Ocular surface disease index, OSDI \< 12 points.
- Non-invasive breakup time, NIBUT \> 11 seconds.
Key Trial Info
Start Date :
February 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03418259
Start Date
February 12 2018
End Date
July 1 2022
Last Update
December 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Källmarkskliniken
Stockholm, Sweden